TL;DR
The U.S. is withholding nearly $600 million from Gavi, the global vaccine alliance, due to disagreements over vaccine policies. This move risks disrupting immunization efforts in poorer nations, potentially causing preventable deaths.
The United States is currently withholding approximately $600 million in funding from Gavi, the Vaccine Alliance, threatening to disrupt immunization programs in low-income countries. This move, driven by political and ideological disagreements, marks a significant shift in U.S. engagement with global vaccine efforts and could lead to increased preventable diseases and deaths worldwide.
Since 2024, the U.S. has not disbursed nearly $600 million allocated for Gavi, the world’s largest vaccine support organization, which the U.S. helped establish and has historically funded heavily. The funds, part of a $1.6 billion pledge for 2024-2030, are now held back amid disputes over vaccine safety and strategy, particularly regarding the use of older, cost-effective vaccines like the diphtheria-tetanus-pertussis (DTwP) shot and the preservative thimerosal.
Officials from the U.S. State Department and HHS have indicated ongoing discussions with Gavi, but no resolution has been reached. The U.S. government, led by figures including Secretary Robert F. Kennedy Jr., has publicly accused Gavi of ignoring scientific evidence and relying on vaccines that Kennedy claims cause harm, despite a lack of supporting data. These claims have influenced the withholding of funds, which are crucial for vaccination campaigns in lower-income countries.
Experts warn that halting these funds risks reversing progress made in global immunization, potentially leading to outbreaks of diseases like diphtheria and pertussis, which Gavi’s supported vaccination efforts have significantly reduced over decades. The disruption could result in thousands of preventable deaths, especially among children in resource-limited settings.
Why It Matters
This development matters because it threatens to undermine decades of progress in global health, risking the resurgence of preventable diseases in vulnerable populations. The U.S. is a major contributor to Gavi, and its withdrawal of funding could weaken international efforts to eradicate deadly illnesses, exacerbate health inequities, and set back global health security.
Vaccination Record: Vaccine for adolescents and adults (Diphtheria – Tetanus – Poliomyelitis – Pertussis-Measles – Mumps – Rubella – Meningitis C – HPV – H epatitis B – Flu …)
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
Gavi was founded in 2000 with significant U.S. support, aiming to increase vaccine access in low-income countries. Over the years, it has helped immunize hundreds of millions of children and saved millions of lives. The U.S. has traditionally been one of Gavi’s largest donors, pledging billions of dollars. Recent political shifts and vaccine debates, especially around vaccine ingredients and safety, have strained U.S.-Gavi relations, leading to the current withholding of funds. The dispute comes amid broader U.S. domestic vaccine skepticism and ideological conflicts over vaccine safety and efficacy. For more context, see how international health organizations like the WHO address vaccine safety concerns.
“Using cheaper vaccines like DTwP is vital in low-resource settings because they require fewer doses and are more affordable, despite some trade-offs in side effects.”
— Seth Berkley, infectious disease expert
“President Trump entrusted Secretary Kennedy to manage the U.S. relationship with Gavi, but discussions are ongoing to find a constructive path forward.”
— U.S. State Department spokesperson
“HHS and State remain cautiously optimistic about a constructive resolution but require more detailed data from Gavi to evaluate the use of U.S. funds.”
— Andrew Nixon, HHS Deputy Assistant Secretary
thimerosal free vaccines for children
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It is unclear when or if the U.S. will release the withheld funds, or what specific conditions Gavi must meet to secure the funding. The exact impact on ongoing vaccination campaigns in specific countries has not yet been fully assessed, and the long-term diplomatic consequences remain uncertain.
low-cost global vaccination kits
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include continued negotiations between the U.S. government and Gavi, with possible resolutions depending on Gavi’s response to vaccine safety and transparency concerns. Monitoring of vaccination campaign impacts in affected countries will be critical, along with potential congressional action to release or reallocate funds.
The Health Bulletin, 1944, Vol. 59
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Why is the U.S. withholding funds from Gavi?
The U.S. cites concerns over vaccine safety, the use of certain vaccine ingredients like thimerosal, and allegations that Gavi has ignored scientific evidence. These claims are disputed and are part of broader political and ideological conflicts.
What could be the impact on global health?
Disruption of Gavi’s funding could lead to reduced immunization coverage in low-income countries, increasing the risk of outbreaks of preventable diseases and causing unnecessary deaths, especially among children.
Are other countries affected?
While the U.S. is a major funder, Gavi receives support from multiple donors. However, the U.S. withholding funds could weaken the organization’s overall capacity and influence its global reach.
Is this dispute related to domestic vaccine debates?
Yes, domestic political debates over vaccine ingredients and safety have influenced U.S. foreign vaccine policy, leading to the current withholding of funds and affecting international vaccination efforts.
Source: The Atlantic
